The use of phytohemagglutinin-stimulated mononuclear cell subpopulations for HLA typing studies involving chronic myelogenous leukemia patients.
D000951:Antigens, Neoplasm / Q000032:analysis*; D016026:Bone Marrow Transplantation; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II / Q000032:analysis*; D006650:Histocompatibility Testing / Q000379:methods*; D006801:Humans; D007951:Leukemia, Myeloid / Q000276:immunology* / Q000628:therapy; D008213:Lymphocyte Activation / Q000187:drug effects; D007959:Lymphocyte Culture Test, Mixed; D010835:Phytohemagglutinins; D011043:Pokeweed Mitogens / Q000494:pharmacology; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000145:classification / Q000187:drug effects / Q000276:immunology*
D000951:Antigens, Neoplasm; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D010835:Phytohemagglutinins; D011043:Pokeweed Mitogens